Novartis AG
FORMULATIONS OF (S)-3-AMINO-6-METHOXY-N-(3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPYL)-5-(TRI- FLUOROMETHYL)PICOLINAMIDE
Last updated:
Abstract:
Provided herein are compounds and pharmaceutical compositions useful for treating bronchiectasis, chronic obstructive pulmonary disorder, cystic fibrosis, chronic bronchitis or asthma comprising administering to a subject in need thereof a therapeutically effective amount of a compound or pharmaceutical composition described herein.
Status:
Application
Type:
Utility
Filling date:
15 Jul 2020
Issue date:
21 Jan 2021